ROCHE DIAGNOSTICS A/S
CVR: 28485085
Secondary names: OBI A/S
The financial health of ROCHE DIAGNOSTICS A/S shows signs of recovery after a challenging period. In 2024, the company reported revenue of 377.3 million DKK and a profit of 8.8 million DKK, marking a return to profitability following a loss of 1.2 million DKK in 2023. However, revenue has significantly declined from 802.3 million DKK in 2022 and 1.4 billion DKK in 2021, indicating a downward trend in sales. The equity position has improved to 54.1 million DKK in 2024, up from 46.7 million DKK in 2023, but remains a concern compared to previous years. Overall, while the company is stabilizing, its declining revenue and past equity challenges highlight the need for strategic adjustments within the competitive pharmaceutical distribution industry.
AI-generated summary
Overview
Details
Purpose
Selskabets formål er markedsføring og salg af diagnostiske instrumenter og ydelser til kliniske laboratorier, sygehuse, læger, m.v., samt al virksomhed som efter bestyrelsens skøn er beslægtet her med.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 377.3 mio. | 8.8 mio. | 141.7 mio. | 54.1 mio. | 103 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area